Bruker, which manufactures scientific instruments for molecular and materials research in addition to industrial and applied analysis, has inked a deal to purchase Oncovision’s pre-clinical imaging business. Oncovision develops medical imaging devices that can be used to diagnose cancer. Undisclosed at the time of the announcement were the financial terms of the agreement.
Read More
GE Healthcare’s MAGiC, which stands for magnetic resonance image compilation, has received 510(k) clearance from the FDA. Providing the industry’s first multi-contrast MR technique, the system provides clinicians with more data than conventional scanning in a much shorter period of time. Users can manipulate MR images retrospectively, and that can lead to substantial time-savings, a reduction in rescans, and an increase in cost savings.
Read More
In October, during “Breast Cancer Awareness Month,” many women will be reminded of the importance of an annual mammogram. This potentially life-saving test has long been an important tool for preventing breast cancer deaths in women 40 and older of average risk. In this article, 24×7 explores all the imaging modalities related to breast imaging.
Read MoreMallinckrodt has entered an agreement to sell its nuclear imaging business to IBA Molecular, which carries a price tag of approximately $690 million. The expectation is this transaction will advance Mallinckrodt’s strategic portfolio to specialty pharmaceuticals. Further, nuclear imaging’s strategic fit with IBA Molecular will benefit patients around the world who depend on medical isotopes.
Read More
Fujifilm has submitted to the FDA the final module of its pre-market approval application for digital breast tomosynthesis as an optional software upgrade for the Aspire Cristalle digital mammography system. Aspire Cristalle, available in the United States as a full-field digital mammography system, features Fujifilm’s hexagonal close-pattern-detector pixel design.
Read More